澳洲资助拉罗尼克斯(Laronix)的AI语音科技, 恢复失声病人的言语。 Australia funds Laronix’s AI voice tech to restore speech for patients who lost their voice.

Laronix是一家澳大利亚医疗技术公司,从澳大利亚政府的工业增长方案获得了320万澳元(210万美元)的非消耗性赠款,以加速开发和商业启动其AI-动力MIRA语音系统。 Laronix, an Australian medical tech company, has secured a AUD $3.2 million (USD $2.1 million) non-dilutive grant from the Australian Government’s Industry Growth Program to accelerate the development and commercial launch of its AI-powered MIRA Voice system. 该技术旨在恢复那些因喉切除、伊斯兰法院联盟插管或帕金森病等神经疾病而失去声音的病人的自然声音。 The technology aims to restore natural-sounding speech for patients who have lost their voice due to laryngectomy, ICU intubation, or neurological conditions like Parkinson’s disease. 拉罗尼克斯以美国和澳大利亚40多家医院使用的现有AVA语音设备为基础,正在推进MIRA-AI系统,这是一个以高度现实主义重塑患者原创声音的人工智能系统。 Building on its existing AVA Voice device used in over 40 hospitals across the U.S. and Australia, Laronix is advancing MIRA-AI, an AI system that recreates a patient’s original voice with high realism. 这笔资金将支持在两年内从原型到临床检测和市场供应的过渡。 The funding will support the transition from prototype to clinical testing and market availability within two years.